Mesenchymal Stem Cells Derived from Adipose Tissue vs Bone Marrow: In Vitro Comparison of Their Tropism towards Gliomas

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Pendleton, Courtney ^a   Li, Qian ^a   Chesler, David A ^a   Yuan, Kristy ^a   Guerrero Cazares, Hugo ^a   Quinones Hinojosa, Alfredo ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD31 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; THY 1 ANTIGEN;

ADIPOSE TISSUE CELL; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL HARVEST VOLUME; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR PARAMETERS; COMPARATIVE STUDY; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PRIMARY CELL CULTURE; STEMNESS; TROPISM; VALIDATION PROCESS; ADIPOSE TISSUE; ANTIBODY SPECIFICITY; CELL LINE; CELL MOTION; CLINICAL TRIAL; COCULTURE; FEMALE; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; COCULTURE TECHNIQUES; FEMALE; GLIOMA; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; ORGAN SPECIFICITY;

EID: 84874850959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058198     Document Type: Article

References (48)

1. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, et al. (2008) Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 63: 700-707; author reply 707-708.
2. Bernstein JJ, Woodard CA, (1995) Glioblastoma cells do not intravasate into blood vessels. Neurosurgery 36: 124-132; discussion 132.
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
4. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, et al. (2006) Chemotherapy resistance of glioblastoma stem cells. Cell death and differentiation 13: 1238-1241.
5. Sakariassen PO, Immervoll H, Chekenya M, (2007) Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 9: 882-892.
6. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, et al. (2000) Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97: 12846-12851.
7. Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, et al. (2009) Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther 16: 262-278.
8. Yuan X, Hu J, Belladonna ML, Black KL, Yu JS, (2006) Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 66: 2630-2638.
9. Lamfers M, Idema S, van Milligen F, Schouten T, van der Valk P, et al. (2009) Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection. Cancer Lett 274: 78-87.
10. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, et al. (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11: 1155-1164.
11. Kosztowski T, Zaidi HA, Quinones-Hinojosa A, (2009) Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther 9: 597-612.
12. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318.
13. Xu F, Zhu JH, (2007) Stem cells tropism for malignant gliomas. Neurosci Bull 23: 363-369.
14. Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, et al. (2009) Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res 15: 4925-4934.
15. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, et al. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.
16. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.
17. Bruder SP, Jaiswal N, Haynesworth SE, (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64: 278-294.
18. Covas DT, Siufi JL, Silva AR, Orellana MD, (2003) Isolation and culture of umbilical vein mesenchymal stem cells. Braz J Med Biol Res 36: 1179-1183.
19. Erices A, Conget P, Minguell JJ, (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
20. Kerkis I, Caplan AI, (2011) Stem cells in dental pulp of deciduous teeth. Tissue Eng Part B Rev.
21. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, et al. (2005) Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 80: 836-842.
22. Rodriguez-Lozano FJ, Bueno C, Insausti CL, Meseguer L, Ramirez MC, et al. (2011) Mesenchymal stem cells derived from dental tissues. Int Endod J 44: 800-806.
23. Huang Q, Liu XZ, Kang CS, Wang GX, Zhong Y, et al. (2009) The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther.
24. Kauer TM, Figueiredo JL, Hingtgen S, Shah K, (2012) Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas. Nat Neurosci 15: 197-204.
25. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C, (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67: 6304-6313.
26. Dembinski JL, Spaeth EL, Fueyo J, Gomez-Manzano C, Studeny M, et al. (2009) Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells. Cancer Gene Ther.
27. Komarova S, Kawakami Y, Stoff-Khalili MA, Curiel DT, Pereboeva L, (2006) Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 5: 755-766.
28. Kucerova L, Matuskova M, Pastorakova A, Tyciakova S, Jakubikova J, et al. (2008) Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 10: 1071-1082.
29. Cavarretta IT, Altanerova V, Matuskova M, Kucerova L, Culig Z, et al. (2009) Adipose Tissue-derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth. Mol Ther.
30. Locke M, Feisst V, Dunbar PR, (2011) Concise review: human adipose-derived stem cells: separating promise from clinical need. Stem Cells 29: 404-411.
31. Yoo KH, Jang IK, Lee MW, Kim HE, Yang MS, et al. (2009) Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259: 150-156.
32. Vilalta M, Degano IR, Bago J, Gould D, Santos M, et al. (2008) Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev 17: 993-1003.
33. Momin EN, Vela G, Zaidi HA, Quinones-Hinojosa A, (2010) The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research. Curr Immunol Rev 6: 137-148.
34. Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, et al. (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track- letter. Cancer Res 70: 6393-6396.
35. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, et al. (2011) Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13: 675-685.
36. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, et al. (2005) Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 54: 132-141.
37. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
38. Guerrero-Cazares H, Chaichana KL, Quinones-Hinojosa A, (2009) Neurosphere culture and human organotypic model to evaluate brain tumor stem cells. Methods Mol Biol 568: 73-83.
39. Bunnell B, Flaat M, Gagliardi C, Patel B, Ripoll C, (2008) Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45: 115-120.
40. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, et al. (2005) Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
41. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, et al. (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109.
42. Zhu Y, Liu T, Song K, Fan X, Ma X, et al. (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26: 664-675.
43. Sun XL, Xu ZM, Ke YQ, Hu CC, Wang SY, et al. (2011) Molecular targeting of malignant glioma cells with an EphA2-specific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells. Cancer Lett 312: 168-177.
44. Fei S, Qi X, Kedong S, Guangchun J, Jian L, et al. (2012) The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. J Cancer Res Clin Oncol 138: 347-357.
45. Roger M, Clavreul A, Menei P, (2011) [Mesenchymal stromal cells as cellular vehicles for delivery of nanoparticles to brain tumors]. Med Sci (Paris) 27: 234-236.
46. Menon LG, Kelly K, Yang HW, Kim SK, Black PM, et al. (2009) Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 27: 2320-2330.
47. Choi SA, Hwang SK, Wang KC, Cho BK, Phi JH, et al. (2011) Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro Oncol 13: 61-69.
48. Momin EN, Mohyeldin A, Zaidi HA, Vela G, Quinones-Hinojosa A, (2010) Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther 5: 326-344.